Nuvaira

About:

Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases.

Top Investors: Qiming Venture Partners, Vertex Ventures, Versant Ventures, U.S. Venture Partners, Richard King Mellon Foundation

Description:

Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases. Nuvaira is currently working on a novel catheter-based system that has the potential to improve lung function, exercise capacity, and quality of life for patients with chronic obstructive pulmonary disease. It was founded in 2008 and headquartered in Minneapolis, Minnesota.

Total Funding Amount:

$204M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Minneapolis, Minnesota, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)nuvaira.com

Founders:

Hanson Gifford, Martin L. Mayse, Steve Dimmer

Number of Employees:

51-100

Last Funding Date:

2024-05-09

IPO Status:

Private

Industries: